Baker Brothers Life Sciences Capital (GP) LLC
Baker Biotech Capital II (GP) LLC
Baker Biotech Capital II (Z) (GP) LLC
Baker Biotech Capital III (Z) (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner | 2013-07-11 17:26:02 | 19,512,451
0 | 19,512,451 | Form 13D |
Baker Biotech Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner | 2013-07-11 17:26:02 | 19,512,451
0 | 19,512,451 | Form 13D |
Baker / Tisch Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner | 2013-07-11 17:26:02 | 19,512,451
0 | 19,512,451 | Form 13D |
14159 capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner | 2013-07-11 17:26:02 | 19,512,451
0 | 19,512,451 | Form 13D |
Baker Bros. Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner | 2013-07-11 17:26:02 | 19,512,451
0 | 19,512,451 | Form 13D |
Baker Brothers Life Sciences Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
Director
10% Owner | 2013-07-11 17:26:02 | 19,512,451
0 | 19,512,451 | Form 13D |
DELPHI MANAGEMENT PARTNERS VI LLC
DELPHI VENTURES VI LP
DELPHI BIOINVESTMENTS VI LP
10% Owner | 2007-01-19 19:49:32 | 1,980,200
2,000,000 | 3,980,200 | Form 4 |
JP MORGAN PARTNERS BHCA LP
JPMP MASTER FUND MANAGER L P
JPMP CAPITAL CORP
JP MORGAN PARTNERS GLOBAL INVESTORS LP
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP
JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P
JPMP GLOBAL INVESTORS L P
10% Owner | 2008-07-29 17:08:03 | 2,733,574
407,958 | 3,141,532 | Form 4 |
H&Q Holdings Inc.
H&Q Employee Venture Fund 2000 L.P.
10% Owner | 2008-07-29 17:07:03 | 2,733,574
407,958 | 3,141,532 | Form 4 |
JP MORGAN PARTNERS BHCA LP
JPMP MASTER FUND MANAGER L P
JPMP CAPITAL CORP
J P MORGAN CHASE & CO
JP MORGAN PARTNERS GLOBAL INVESTORS LP
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JPMP GLOBAL INVESTORS L P
10% Owner | 2008-07-21 16:20:29 | 2,263,980
0 | 2,263,980 | Form 13D |
JP MORGAN PARTNERS BHCA LP
JPMP MASTER FUND MANAGER L P
JP MORGAN PARTNERS GLOBAL INVESTORS LP
JPMP CAPITAL LLC
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JPMP GLOBAL FUND BILL BARRETT SELLDOWN LP
JPMP GLOBAL INVESTORS L P
10% Owner | 2008-07-21 16:20:29 | 2,263,980
0 | 2,263,980 | Form 13D |
JP MORGAN PARTNERS BHCA LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JP MORGAN PARTNERS GLOBAL INVESTORS LP
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
JPMP GLOBAL INVESTORS L P
JP MORGAN CHASE BANK
JPMP CAPITAL CORP
JPMP MASTER FUND MANAGER L P
10% Owner | 2008-07-21 16:20:29 | 2,263,980
0 | 2,263,980 | Form 13D |
JP MORGAN PARTNERS BHCA LP
JPMP MASTER FUND MANAGER L P
JPMP CAPITAL CORP
JP MORGAN PARTNERS GLOBAL INVESTORS LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP
J P MORGAN PARTNERS GLOBAL INVESTORS A LP
J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP
JPMP GLOBAL FUND BILL BARRETT SELLDOWN LP
JPMP GLOBAL INVESTORS L P
10% Owner | 2008-07-21 16:20:29 | 2,263,980
0 | 2,263,980 | Form 13D |
TrailSmith Pamela A
Chief Scientific Officer | 2007-05-18 20:28:16 | 1,755,235
0 | 1,755,235 | Form 4 |
GALLEN JONATHAN
Former 10% Owner | 2009-02-17 09:23:20 | 1,614,125
0 | 1,614,125 | Form 13G |
FELL H PERRY
Chairman | 2003-12-02 18:58:42 | 1,294,000
0 | 1,294,000 | Form 4 |
SIEGALL CLAY B
President & CEO | 2022-05-13 19:13:16 | 778,911
0 | 778,911 | Form 4 |
POWELL MICHAEL
Director | 2004-12-16 18:40:49 | 20,001
647,577 | 667,578 | Form 4 |
BERGER FRANKLIN M
Director | 2014-02-25 18:04:20 | 204,720
0 | 204,720 | Form 4 |
Reynolds Thomas C
Chief Medical Officer | 2013-01-29 20:16:09 | 175,095
0 | 175,095 | Form 4 |
DOBMEIER ERIC
Chief Operating Officer | 2017-12-06 20:04:46 | 144,560
0 | 144,560 | Form 4 |
BOERNER CHRISTOPHER S.
Executive Vice President, Comm | 2014-08-27 16:22:43 | 112,358
0 | 112,358 | Form 4 |
Cline Darren S
EVP, Commercial | 2018-11-30 18:32:35 | 72,556
0 | 72,556 | Form 4 |
SEELEY BRUCE J.
EVP, Commerical | 2011-08-24 20:41:14 | 68,861
0 | 68,861 | Form 4 |
SENTER PETER
Vice President, Chemistry | 2003-08-22 12:23:47 | 68,148
0 | 68,148 | Form 4 |
CARROLL TIM
CFO | 2005-05-05 18:32:49 | 62,861
0 | 62,861 | Form 4 |
LIPPMAN MARC E
Director | 2021-05-18 19:29:12 | 57,202
0 | 57,202 | Form 4 |
ROSENBERG MORRIS
EVP, Process Sciences | 2012-06-14 19:51:20 | 54,077
0 | 54,077 | Form 4 |
SING AMY
Sr. Director Medical Affairs | 2003-08-18 18:59:49 | 52,107
0 | 52,107 | Form 4 |
MCDONALD MICHAEL
Chief Medical Officer | 2005-02-02 19:28:59 | 50,000
0 | 50,000 | Form 4 |
MCLAUGHLIN JOHN PETER
Director | 2016-05-24 20:11:49 | 48,660
0 | 48,660 | Form 4 |
AKKARAJU SRINIVAS
Director | 2020-05-19 19:10:02 | 44,674
0 | 44,674 | Form 4 |
TAYLOR ROBIN G
Chief Commercial Officer | 2019-12-23 17:14:08 | 33,025
0 | 33,025 | Form 4 |
WILLIAMS DOUGLAS E
CSO, EVP R&D | 2004-02-19 14:09:41 | 25,000
0 | 25,000 | Form 4 |
FBB2 LLC
Director
10% Owner | 2012-06-18 17:38:49 | 18,243
0 | 18,243 | Form 3 |
Hoth Daniel Floyd JR
Director | 2010-05-25 17:08:45 | 17,500
0 | 17,500 | Form 4 |
FBB3 LLC
Director
10% Owner | 2014-12-11 17:02:34 | 12,678
0 | 12,678 | Form 3 |
DRACHMAN JONATHAN G
See Remarks | 2018-03-22 21:36:51 | 10,526
0 | 10,526 | Form 4 |
SOUTHERN DOUGLAS
Director | 2006-05-19 18:48:16 | 10000
0 | 10000 | Form 4 |
HELLSTROM KARL ERIK
Director | 2004-05-18 15:11:44 | 10000
0 | 10000 | Form 4 |
BAKER BROS. ADVISORS LP
667 L.P.
BAKER JULIAN
BAKER FELIX
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Former 10% Owner
Director | 2023-12-18 18:46:48 | 0
0 | 0 | Form 4 |
HIMES VAUGHN B
Chief Technical Officer | 2023-12-15 18:55:41 | 0
0 | 0 | Form 4 |
Simonian Nancy A
Director | 2023-12-15 18:46:58 | 0
0 | 0 | Form 4 |
SIMPSON TODD E
Chief Financial Officer | 2023-12-15 18:42:41 | 0
0 | 0 | Form 4 |
LOVE TED W
Director | 2023-12-15 18:39:32 | 0
0 | 0 | Form 4 |
SWAIN SANDRA M
Director | 2023-12-15 18:38:08 | 0
0 | 0 | Form 4 |
LIU JEAN I
Chief Legal Officer | 2023-12-15 18:32:04 | 0
0 | 0 | Form 4 |
WELCH DANIEL G
Director | 2023-12-15 18:31:12 | 0
0 | 0 | Form 4 |
Epstein David R
CEO | 2023-12-15 18:29:19 | 0
0 | 0 | Form 4 |
Seth Alpna
Director | 2023-12-15 18:24:45 | 0
0 | 0 | Form 4 |
GRYSKA DAVID W
Director | 2023-12-15 18:16:57 | 0
0 | 0 | Form 4 |
ROMP CHARLES R
EVP, Commercial U.S. | 2023-12-15 18:16:13 | 0
0 | 0 | Form 4 |
Orwin John A
Director | 2023-12-15 18:10:54 | 0
0 | 0 | Form 4 |
DANSEY ROGER D
President, R&D & CMO | 2023-12-15 18:10:33 | 0
0 | 0 | Form 4 |
CASCADE INVESTMENT LLC
Formerly a 10% Owner | 2006-02-24 16:16:12 | 0
0 | 0 | Form 13G |
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
BAKER BROS. ADVISORS LP
667 L.P.
Baker Brothers Life Sciences LP
14159 L.P.
Director
10% Owner | 2023-12-18 17:25:33 | 0
0 | 0 | Form 13D |